Log in to save to my catalogue

Medication Exposure in Pregnancy Risk Evaluation Program: The Prevalence of Asthma Medication Use Du...

Medication Exposure in Pregnancy Risk Evaluation Program: The Prevalence of Asthma Medication Use Du...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3797257

Medication Exposure in Pregnancy Risk Evaluation Program: The Prevalence of Asthma Medication Use During Pregnancy

About this item

Full title

Medication Exposure in Pregnancy Risk Evaluation Program: The Prevalence of Asthma Medication Use During Pregnancy

Publisher

Boston: Springer US

Journal title

Maternal and child health journal, 2013-11, Vol.17 (9), p.1611-1621

Language

English

Formats

Publication information

Publisher

Boston: Springer US

More information

Scope and Contents

Contents

Asthma is one of the most common chronic diseases in women of reproductive age, occurring in up to 8 % of pregnancies. The objective of this study is to assess the prevalence of asthma medication use during pregnancy in a large diverse cohort. We identified women aged 15–45 years who delivered a live born infant between 2001 and 2007 across 11 U.S....

Alternative Titles

Full title

Medication Exposure in Pregnancy Risk Evaluation Program: The Prevalence of Asthma Medication Use During Pregnancy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3797257

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3797257

Other Identifiers

ISSN

1092-7875

E-ISSN

1573-6628

DOI

10.1007/s10995-012-1173-x

How to access this item